AIMS: Home-made preparation of heroin is common in countries of the former Soviet Union (FSU), and the addition of blood during its preparation and the use of contaminated syringes to distribute it may play a role in the rapid spread of HIV-1 among injecting drug users (IDUs). This study was designed to determine the viability of HIV-1 during these procedures. SETTING: Field observations of home-made opiate manufacture in four FSU countries were used to develop a consensus protocol to replicate manufacture in the laboratory that included the addition of human blood contaminated with HIV-1. DESIGN AND MEASUREMENT: Following the addition of HIV-1-contaminated blood during manufacture or storage, we attempted to recover viable HIV-1. The recovery was measured by propagation of the virus in stimulated white blood cells from uninfected donors. FINDINGS: In experiments in which HIV-1 contaminated blood was added during manufacture, no viable HIV-1 was recovered. In experiments in which chornaya was introduced into HIV-contaminated syringes, the percentage of syringes containing viable HIV-1 was reduced. The reduction appeared to be related to the interaction of HIV-1 contaminated blood with a component of the poppies. While HIV-contaminated syringes used to dispense or inject home-made opiates might transmit HIV, the ability of chornaya to reduce HIV viability seems to make this route of transmission less efficient. CONCLUSIONS: The epidemic of HIV-1 among IDUs in the FSU resulted more probably from recognized injection risk behaviors-including sharing syringes and drug solutions--than from opiate solutions harboring viable HIV-1.
AIMS: Home-made preparation of heroin is common in countries of the former Soviet Union (FSU), and the addition of blood during its preparation and the use of contaminated syringes to distribute it may play a role in the rapid spread of HIV-1 among injecting drug users (IDUs). This study was designed to determine the viability of HIV-1 during these procedures. SETTING: Field observations of home-made opiate manufacture in four FSU countries were used to develop a consensus protocol to replicate manufacture in the laboratory that included the addition of human blood contaminated with HIV-1. DESIGN AND MEASUREMENT: Following the addition of HIV-1-contaminated blood during manufacture or storage, we attempted to recover viable HIV-1. The recovery was measured by propagation of the virus in stimulated white blood cells from uninfected donors. FINDINGS: In experiments in which HIV-1 contaminated blood was added during manufacture, no viable HIV-1 was recovered. In experiments in which chornaya was introduced into HIV-contaminated syringes, the percentage of syringes containing viable HIV-1 was reduced. The reduction appeared to be related to the interaction of HIV-1 contaminated blood with a component of the poppies. While HIV-contaminated syringes used to dispense or inject home-made opiates might transmit HIV, the ability of chornaya to reduce HIV viability seems to make this route of transmission less efficient. CONCLUSIONS: The epidemic of HIV-1 among IDUs in the FSU resulted more probably from recognized injection risk behaviors-including sharing syringes and drug solutions--than from opiate solutions harboring viable HIV-1.
Authors: Sergii Dvoriak; Andrey Karachevsky; Sumedha Chhatre; Robert Booth; David Metzger; Joseph Schumacher; Nina Chychula; Anna Pecoraro; George Woody Journal: Drug Alcohol Depend Date: 2014-01-30 Impact factor: 4.492
Authors: Ksenia Eritsyan; Robert Heimer; Russell Barbour; Veronika Odinokova; Edward White; Maia M Rusakova; Tatiana T Smolskaya; Olga S Levina Journal: BMJ Open Date: 2013-06-20 Impact factor: 2.692
Authors: V Anna Gyarmathy; Alan Neaigus; Nan Li; Eszter Ujhelyi; Irma Caplinskiene; Saulius Caplinskas; Carl A Latkin Journal: Eur Addict Res Date: 2010-08-26 Impact factor: 3.015
Authors: Kathryn E Lancaster; Irving F Hoffman; Brett Hanscom; Tran Viet Ha; Kostyantyn Dumchev; Hepa Susami; Scott Rose; Vivian F Go; Sarah A Reifeis; Katie R Mollan; Michael G Hudgens; Estelle M Piwowar-Manning; Paul Richardson; Sergii Dvoriak; Zubairi Djoerban; Tetiana Kiriazova; Oleksandr Zeziulin; Samsuridjal Djauzi; Chu Viet Ahn; Carl Latkin; David Metzger; David N Burns; Jeremy Sugarman; Steffanie A Strathdee; Susan H Eshleman; William Clarke; Deborah Donnell; Lynda Emel; Lisa E Sunner; Laura McKinstry; Nirupama Sista; Erica L Hamilton; Jonathan P Lucas; Bui D Duong; Nguyen Van Vuong; Riza Sarasvita; William C Miller Journal: J Int AIDS Soc Date: 2018-10 Impact factor: 5.396